CC3

On-Scene: Taking ECPR to the patient. A game changer for refractory cardiac arrest?

The On-Scene study reports almost double the survival to hospital discharge in selected patients with refractory out-of-hospital cardiac arrest treated within a prehospital ECPR-capable system. With survival of 40% versus 20%, and substantially shorter times to extracorporeal circulation, could bringing ECMO to the patient transform cardiac arrest care? We examine the findings, limitations and implications for emergency medicine, HEMS and future resuscitation systems.

On-Scene: Taking ECPR to the patient. A game changer for refractory cardiac arrest? Read More

REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s

A June 2021 review of early RECOVERY results for casirivimab and imdevimab in hospitalised COVID-19 patients. It explains the reported mortality benefit in patients without detectable antibodies, why that finding did not extend to the whole trial population, and the preliminary evidence available then.

REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More

Scroll to Top